J84.170
BillableInterstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere
HCC Category Mapping
What This Code Means
Progressive scarring of lung tissue that develops as part of another disease, leading to worsening lung function over time.
Coding Tips
- •Always code the underlying disease first, then use this code as a secondary diagnosis
- •Ensure documentation clearly indicates progressive fibrotic phenotype
Clinical Significance
Interstitial lung disease with progressive fibrotic phenotype represents a subset of ILDs that behave like IPF with relentless fibrotic progression despite treatment. This is a high-severity manifestation code used as a secondary diagnosis alongside the underlying condition. The progressive fibrotic phenotype indicates patients eligible for antifibrotic therapy regardless of their underlying ILD, reflecting very high resource utilization.
Documentation Requirements
- ✓Documentation of the underlying disease classified elsewhere (e.g., rheumatoid arthritis-ILD, hypersensitivity pneumonitis, sarcoidosis)
- ✓Evidence of progressive fibrotic phenotype: declining forced vital capacity, worsening fibrosis on serial imaging, or worsening symptoms despite treatment
- ✓Serial imaging (high-resolution computed tomography) showing progressive fibrotic changes over time
- ✓Pulmonary function test trends demonstrating decline
- ✓Code the underlying disease first, then J84.170 as a secondary/manifestation code